Patient Advocates

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.


Registration Category & Fees


The patient advocate registration category is reserved exclusively for patient advocates and is not intended for medical professionals. Individuals interested in registering under this category either work or volunteer for national not-for-profit patient advocacy organizations that demonstrate a charitable mission, engage in patient advocacy activities, provide support for people with cancer, have a nonprofessional membership, do not offer CME or scientific programs for professionals.

Category Price
Until 10/31/17 $150.00
Beginning 11/1/17 $225.00

Pre-registration discount ends October 31, 2017
Pre-registration closes November 11, 2017
On site registration opens December 4, 2017


Patient Advocate Mentor Sessions

The Alamo Breast Cancer Foundation runs a grassroots advocacy program to eradicate the presence of breast cancer in our society.

Every year, Alamo Breast Cancer Foundation sponsors special mentoring sessions for patient advocates at SABCS. These usually take place 6 PM – 8 PM on Wednesday, Thursday & Friday during the symposium.

Leading experts in the field of breast cancer provide commentary on symposium presentations and responding to advocates’ questions about the relevance of this scientific data.

Click here to view the 2015 Hot Topic Mentor Sessions.


Financial Assistance

Every year the Alamo Breast Cancer Foundation provides scholarships for eligible breast cancer advocates to attend the annual San Antonio Breast Cancer Symposium, and take part in Mentor Sessions.

Website
Information regarding the 2017 ABCF Advocate Program can be found at
www.alamobreastcancer.org. This page also includes a link to an on line application.

E-Mail sandistanford@alamobreastcancer.org for information and an application.

All applications for financial assistance must be submitted by 10PM CST by September 1, 2017.


Advocate Program

The 20th Annual Advocate Program is sponsored by Alamo Breast Cancer Foundation (ABCF), a non-profit 501[c]3 organization. This San Antonio-based grassroots advocacy, educational, and support organization was established for women and men with breast cancer and for those concerned about breast cancer issues. ABCF is active locally and nationally (as members of the National Breast Cancer Coalition) in their goal to eradicate breast cancer in our lifetime.

The 1st Annual Advocate Program was held in 1998, in conjunction with the 21st Annual San Antonio Breast Cancer Symposium, as an educational program specially designed to address the needs of patient advocates and those who support them. The program for 2017 will include Orientation, Dinner, Mentors Program, two Educational programs and Breast Cancer Update for the grant recipients. 30-40 travel grants are expected to be available for 2017, pending receipt of sufficient grant funds.

The administration of this program is handled entirely by Alamo Breast Cancer Foundation. Their 2017 proposal will be mailed to a select list in June, and we hope you will support their program in addition to the 40th Annual San Antonio Breast Cancer Symposium.

Contact Information:
Sandi Stanford
Alamo Breast Cancer Foundation
PO Box 780067
San Antonio, TX 78278
Email: sandistanford@alamobreastcancer.org
Website Address: www.alamobreastcancer.org

Year Funding Sources # Travel Grants Applications # Travel Grants Awarded Total # Advocate Registration to SABCS
1998 Glaxo Wellcome Eli Lilly Zeneca 14 14 82
1999 Bristol-Myers Genentech Wyeth-Ayerst 42 30 104
2000 Aventis Genentech AstraZeneca Glaxo Wellcome Pharmacia Oncology 62 50 123
2001 AstraZeneca Aventis Bristol-Meyers Squibb Chroma Vision Eli Lilly Genentech GlaxoSmithKline Pharmacia 52 36 118
2002 AstraZeneca Aventis Bristol-Myers Squibb ChromaVision DakoCytomation Eli Lilly Genentech GlaxoSmithKline Pharmacia 40 28 119
2003 AstraZeneca Pharmaceuticals Bristol Myers Squibb Chromavision DakoCytomation Eli Lilly & Co Genentech Genomic Health GlaxoSmithKline Pfizer 52 37 168
2004 AstraZeneca Pharmaceuticals DakoCytomatic, Inc. Genentech, Inc. Genomic Health, Inc. GlaxoSmithKline Introgen Therapeutics, Inc. Sanofi-Aventis 52 37 168
2005 AstraZeneca Pharmaceuticals Cytyc Eli Lilly & Company Genentech Genomic Health GlaxoSmithKline Introgen Therapeutics Sanofi-Aventis 49 32 201
2006 Avon Foundation NBCC Fund--Best Practices Award AstraZeneca Genentech Genomic Health Eli Lilly Sanofi-Aventis 109 43 199
2007 Abraxis Oncology AstraZeneca Avon Foundation Genentech GlaxoSmithKline Novartis Roche Introgen Therapeutics Sanofi-Aventis Dr. Sharon Wilks 109 42 233
2008 Abraxane-AZ AstraZeneca Avon Foundation Cytori Genentech BioOncology Genomic Health, Inc. GlaxoSmithKline Her2 Support Novartis Roche Sanofi-Aventis Dr. Sharon Wilks 34 32 225
2009 Abraxis BioOncology AstraZeneca Avon Foundation for Women Cytori Therapeutics, Inc Eli Lilly & Co Genentech Genomic Health, Inc GlaxoSmithKline Her2 Support Group Organization National Breast Cancer Coalition Novartis Pharmaceuticals Corp Sanofi-Aventis Dr. Sharon Wilks, MD, FACP Dr. Peter Ravdin, MD, PhD 82 36 235
2010 AACR Abraxis BioOncology Amgen AstraZeneca Avon Foundation for Women Eisai, Inc. Eli Lilly & Co. Genentech GlaxoSmithKline Novartis Pharmaceuticals Corporation Dr. Peter Ravdin, MD, PhD Sanofi-Aventis Dr Sharon Wilks, MD, FACP 107 32 297
2011 AACR Amgen Avon Foundation for Women Boehringer Ingelheim Genentech Genomic Health, Inc. GlaxoSmithKline Julie Ann Carpenter Memorial Fund Novartis Pharmaceuticals Corp Peter Ravdin, MD, PhD Sharon Wilks, MD, FACP Syndax 119 41 298
2012 AACR Amgen Avon Foundation for Women Celgene Corporation Genentech Genomic Health, Inc GlaxoSmithKline Julie Ann Carpenter Memorial Fund Nektar Novartis Pharmaceuticals Corp Peter Ravdin, MD, PhD 68 31 144
2013 AACR Amgen AstraZeneca Avon Foundation for Women Celgene Corporation Genentech Genomic Health Julie Ann Carpenter Memorial Fund Novartis Pharmaceuticals Peter Ravdin, MD, PhD SABCS Sharon Wilks, MD, FACP 61 23 171
2014 AACR Amgen AstraZeneca Avon Foundation for Women DARA BioSciences Eisai Genentech Genomic Health, Inc Julie Ann Carpenter Memorial Fund NanoString Technologies Nektar Therapeutics Novartis Pharmaceuticals Nuclea Diagnostics Peter Ravdin, MD, PhD Pfizer SABCS Syndax 78 28 229
2015  AACR Amgen Oncology AstraZeneca Pharmaceuticals
Avon Foundation for Women Eisai Inc. Genentech BioOncology
Genomic Health, Inc. Julie Ann Carpenter Memorial Fund
NanoString Technologies Navidea Biopharmaceuticals Nektar Therapeutics Novartis Oncology Recycledman Foundation SABCS Susan G. Komen Syndax Pharmaceuticals 
71  28 196
2016  AACR Amgen Oncology AstraZeneca Pharmaceuticals
Avon Foundation for Women Biotheranostics, Inc. Cascadian Therapeutics Eisai Genentech BioOncology Genomic Health Julie Ann Carpenter Memorial Fund Lumicell
M-3 Health Communications NanoString Technologies
Nektar Therapeutics Novartis Oncology Pfizer The Recycledman Foundation Syndax Pharmaceuticals SABCS Susan G. Komen  
 63  34 180